(Q35772023)

10 August 2017

1 reference

title

Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells (English)

1 reference

10 August 2017

2

Joel F Habener

1 reference

10 August 2017

James F List

1

1 reference

10 August 2017

publication date

1 June 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

10 August 2017

published in

1 reference

10 August 2017

volume

286

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

E875-81

1 reference

Gut peptides and type 2 diabetes mellitus treatment

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Molecular development of the pancreatic β cell: implications for cell replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

21 January 2018

Pancreatic stem cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Growth and development of the islets of Langerhans: implications for the treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

21 January 2018

Glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Biological actions and therapeutic potential of the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Factors controlling pancreatic cell differentiation and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Cell replacement therapy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Insulin-promoter-factor 1 is required for pancreas development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Beta cell proliferation and growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Generation of islets of Langerhans from adult pancreatic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Multipotential phenotypic expression of genes encoding peptide hormones in rat insulinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Expression of the receptor tyrosine kinase KIT in mature beta-cells and in the pancreas in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

In-vitro differentiation of pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Regeneration therapy of pancreatic beta cells: towards a cure for diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Expression of a novel zinc-finger cDNA, IA-1, is associated with rat AR42J cells differentiation into insulin-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

The stem cell factor-c-kit system and mast cells in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00007.2004

10.1152/AJPENDO.00007.2004

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference